Literature DB >> 3733684

Tumor necrosis factor induces synthesis of two proteins in human fibroblasts.

M Kirstein, C Baglioni.   

Abstract

Human fibroblasts were insensitive to tumor necrosis factor (TNF) alone but were killed when treated with TNF together with the inhibitor of protein synthesis cycloheximide. However, incubation with TNF before addition of cycloheximide protected these cells from cytotoxicity. This suggested that TNF induced some protective mechanism(s) and that protein synthesis was required for this induction. By labeling fibroblasts with [35S]methionine, we observed that TNF induced in these cells the synthesis of two proteins of Mr 36,000 and 42,000 (p36 and p42). This induction was dependent on the TNF concentration and was observed within a few hours after addition of TNF. Actinomycin D prevented synthesis of these proteins, suggesting that TNF induced transcription of the corresponding mRNAs. p42 appeared to be stable, whereas p36 turned over within a few hours. The physiological role of these proteins in the cellular response to TNF remains to be established.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733684

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Signalling pathway of tumor necrosis factor in normal and tumor cells.

Authors:  N Watanabe; H Neda; Y Ohtusuka; H Sone; N Yamauchi; M Maeda; H Kuriyama; Y Niitsu
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.

Authors:  P Krajcsi; T Dimitrov; T W Hermiston; A E Tollefson; T S Ranheim; S B Vande Pol; A H Stephenson; W S Wold
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 3.  Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation.

Authors:  B Beutler; A Cerami
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

4.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.

Authors:  P Schwenger; P Bellosta; I Vietor; C Basilico; E Y Skolnik; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

6.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts.

Authors:  J M Boss; S M Laster; L R Gooding
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

8.  Common expression of a tumor necrosis factor resistance mechanism among gynecological malignancies.

Authors:  C B Powell; D G Mutch; L S Massad; M S Kao; J L Collins
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells.

Authors:  Y Nio; J Zighelboim; J Berek; B Bonavida
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

10.  A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes.

Authors:  T M Horton; A E Tollefson; W S Wold; L R Gooding
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.